Carlisle Companies
CSL on NYSE. Carlisle Companies sells blood plasma medicines and vaccines to hospitals and patients. Market value $13.1bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Worth a closer look
Why it could be worth it
What to watch out for
Nothing stood out in the numbers we check.
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $6.59 of spare cash in the past 12 months. A savings account pays about $4.
You pay 15.1 years of operating profit for the business. The average large US company costs around 18.
Each dollar kept in the business earns 18 cents a year. Above 10 is good.
Quality score: 93 of 100. Price score: 91 of 100. Our list needs 70 on quality and 60 on price.
$330.98 a share, 13% above its 1-year low
Over the past year the price has ranged from $293.43 to $432.91.
Dividend: 1.4% a year
Paid every year for at least 5 years
Prices from Monday’s close (5 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $3.8bn | $5.4bn | $4.6bn | $5.0bn | $5.0bn |
| Operating margin | |||||
| Operating margin | 14.9% | 22.1% | 21.4% | 22.8% | 20.0% |
| Debt to equity | |||||
| Debt to equity | 1.11 | 0.85 | 0.81 | 0.77 | 1.61 |
| Shares outstanding | |||||
| Shares outstanding | 0.05bn | 0.05bn | 0.05bn | 0.04bn | 0.04bn |
Health checks
- Free cash flow positive5 of 5 years
- Accounting looks honest (Beneish)Nothing unusual
- Financial strength (Piotroski)6 of 9
- Profit backed by cash (accruals)Yes
- Debt1.61× equity
- Revenue growth, five yearsSlow, 4.8% a year
- Buying back its own sharesYes, 23% fewer since 2021
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $1.6 billion last quarter, up 8% on a year ago.
- Profit: $255 million, about the same as a year ago.
- It keeps 20 cents of each $1 of sales as operating profit, down from 21 cents a year earlier.
- Spare cash over the past 12 months: $867 million, up from $859 million.
- 7% fewer shares than a year ago. Each share owns a bit more of the company.
- Debt is $2.2 billion more than cash, up from $1.8 billion a year ago.
- Sales grew on a year ago in 3 of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| September 2024 | $1.3bn |
| December 2024 | $1.1bn |
| March 2025 | $1.1bn |
| June 2025 | $1.4bn |
| September 2025 | $1.3bn |
| December 2025 | $1.1bn |
| March 2026 | $1.1bn |
| June 2026 | $1.6bn |
| Quarter to | Amount |
|---|---|
| September 2024 | $244m |
| December 2024 | $163m |
| March 2025 | $143m |
| June 2025 | $256m |
| September 2025 | $214m |
| December 2025 | $127m |
| March 2026 | $128m |
| June 2026 | $255m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 13 February 2026
- Next quarterly (estimated, 10-Q)
- 29 October 2026
Who owns it
13 long-term investors we follow own it, unchanged from 13 last quarter. 796 funds in all.
- First Pacific Advisors (FPA)Steven Romick
- Value
- $954,758
- Share of fund
- <0.1%
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| First Eagle Investment ManagementMatthew McLennan | $896m | 0.7% | Added |
| First Manhattan Co.First Manhattan partners | $170m | 0.4% | Added |
| Fiduciary Management (FMI)Pat English | $163m | 2.3% | Cut |
| Boston PartnersBoston Partners team | $160m | 0.1% | Added |
| Cooke & BielerCooke & Bieler partners | $118m | 1.4% | Added |
| AKO CapitalNicolai Tangen (founder) | $69m | 1.6% | Cut |
| Gotham Asset ManagementJoel Greenblatt | $7m | <0.1% | Added |
| Heartland AdvisorsBill Nasgovitz | $6m | 0.3% | Added |
| GMOJeremy Grantham | $6m | <0.1% | Cut |
| Mawer Investment ManagementMawer team | $5m | <0.1% | Cut |
| Polaris Capital ManagementBernard Horn | $2m | 0.2% | Added |
| Harris Associates (Oakmark)Bill Nygren | $2m | <0.1% | Cut |
| First Pacific Advisors (FPA)Steven Romick | $954,758 | <0.1% |
Largest holders overall
- BlackRock$1.5bnCut
- Morgan Stanley$901mCut
- First Eagle Investment Management$896mAdded
- State Street$761mAdded
- Vanguard Portfolio Management$714m
- Vanguard Capital Management$663m
- Bank of New York Mellon$405mCut
- Franklin Resources$290mCut
- Sands Capital Management$290mCut
- Geode Capital Management$278m
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
3 investors own more than 5%.
- Vanguard Capital ManagementPassive investor5.2%Since 31 March 2026
- STATE STREET CORPORATIONPassive investor5.2%+0.2 ptsSince 30 June 2026
- Morgan StanleyPassive investorat least 5.1%−1.3 pts(filed with 1 related holder)Since 31 March 2026
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Vanguard Capital Management Passive investor | 5.2% | 31 March 2026 | |
STATE STREET CORPORATION Passive investor | 5.2%+0.2 pts | 30 June 2026 | |
Morgan Stanley Passive investor | at least 5.1%−1.3 pts (filed with 1 related holder) | 31 March 2026 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 5 sold $28m.
- Easton Andrew CVP & Chief Accounting OfficerSold
- Date
- 19 February 2026
- Shares
- 233
- Price
- $407.57
- Value
- $94,964
- Schwar StephenVice Chair of CCMSold
- Date
- 12 February 2026
- Shares
- 6,049
- Price
- $417.36
- Value
- $3m
- SMITH DAVID WVP, SustainabilitySold
- Date
- 10 February 2026
- Shares
- 1,800
- Price
- $414.05
- Value
- $745,290
- Zdimal Kevin PVP & Chief Financial OfficerSold
- Date
- 10 February 2026
- Shares
- 24,180
- Price
- $408.04
- Value
- $10m
- KOCH D CHRISTIANChair, President & CEOSold
- Date
- 10 February 2026
- Shares
- 36,260
- Price
- $413.38
- Value
- $15m
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 19 February 2026 | Easton Andrew C VP & Chief Accounting Officer | Sold | 233 | $407.57 | $94,964 |
| 12 February 2026 | Schwar Stephen Vice Chair of CCM | Sold | 6,049 | $417.36 | $3m |
| 10 February 2026 | SMITH DAVID W VP, Sustainability | Sold | 1,800 | $414.05 | $745,290 |
| 10 February 2026 | Zdimal Kevin P VP & Chief Financial Officer | Sold | 24,180 | $408.04 | $10m |
| 10 February 2026 | KOCH D CHRISTIAN Chair, President & CEO | Sold | 36,260 | $413.38 | $15m |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 13 Feb 2026, plus the 10-Q filed 30 Jul 2026 and 4 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
What changed in the risks this year
Companies must list what could hurt them each year. These are the parts that changed since last year’s report.
The Company could face product liability claims, and we may not have sufficient insurance to cover those claims.
Could happenOur building products are used in a wide variety of commercial, residential and industrial applications. We face an inherent risk of exposure to product liability or other claims in the event our products are alleged to be defective or that the use of our products is alleged to have resulted in harm to others or their property. If product liability lawsuits against us are successful, it could have an adverse impact on our financial condition and results of operations. Moreover, any such lawsuits, whether or not successful, could result in adverse publicity to us, which could harm our reputation and cause our sales to decline. We maintain insurance coverage to protect us against product liability Table of Content s claims, but that coverage may not be adequate to cover all claims that may arise, or we may not be able to maintain adequate insurance coverage in the future at an acceptable cost. Any liability not covered by insurance or that exceeds our established reserves could materially and adversely impact our business, financial condition and results of operations.
Read moreThe development and introduction of new products, or the failure to do so, could have a material adverse effect on our business, financial condition, results of operations or cash flows.
Could happenA key pillar of the Company’s Vision 2030 strategic plan is driving growth through continued investment in new product innovation. Our likelihood of success in investing in new products must be considered in light of the expenses, difficulties and delays frequently encountered in connection with the early phases of new product development, including the difficulties involved in obtaining permits and regulatory approvals, planning and constructing new manufacturing facilities, and establishing, maintaining or expanding customer relationships. While Table of Content s we strive to introduce new products, our efforts to develop and market new products may be unsuccessful or unprofitable, which could adversely affect our business, financial condition, results of operations or cash flows.
Read moreThe Company could be adversely affected by any significant damage to, or prolonged disruption of, our manufacturing facilities.
Could happenThe Company has made substantial investments in manufacturing facilities, and many products are produced at a limited number of locations. These facilities could be materially damaged or operations at these facilities could be materially disrupted by natural disasters, such as floods, tornados, hurricanes, fires and earthquakes, as well as governmental or administrative actions, regulatory issues, civil unrest, industrial accidents, unavailability or excessively high cost of raw materials, mechanical equipment failure, human error, cybersecurity breaches, widespread health emergencies, theft, sabotage or other reasons. We could incur uninsured losses and liabilities arising from such events, including damage to our reputation, or suffer material losses in operational capacity, which could have a material adverse impact on our business, financial condition, results of operations or cash flows.
Read moreThe Company’s growth strategy is partially dependent on the acquisition and successful integration of other businesses.
Could happenA key pillar of the Company’s Vision 2030 strategic plan is building scale with synergistic acquisitions. When companies become available for purchase, the process is often highly competitive, which tends to result in relatively high valuations for the target company. There can be no assurance that the Company will be able to continue to identify, negotiate and finance suitable acquisitions at values the Company considers reasonable.
Read more
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.